DC Funds, LP 13F Holdings · Q2 2026
DC Funds, LP reported 3 securities worth $1.25M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: TCRX (49.27%), BRNS (33.82%), HOWL (16.92%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TCRX | TSCAN THERAPEUTICS INC | $617,463 | 49.27% | 630,000 | Hold |
| 2 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $423,855 | 33.82% | 642,204 | Hold |
| 3 | HOWL | WEREWOLF THERAPEUTICS INC | $212,018 | 16.92% | 589,102 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR